Page last updated: 2024-10-22

acetazolamide and Peripheral Arterial Disease

acetazolamide has been researched along with Peripheral Arterial Disease in 1 studies

Acetazolamide: One of the CARBONIC ANHYDRASE INHIBITORS that is sometimes effective against absence seizures. It is sometimes useful also as an adjunct in the treatment of tonic-clonic, myoclonic, and atonic seizures, particularly in women whose seizures occur or are exacerbated at specific times in the menstrual cycle. However, its usefulness is transient often because of rapid development of tolerance. Its antiepileptic effect may be due to its inhibitory effect on brain carbonic anhydrase, which leads to an increased transneuronal chloride gradient, increased chloride current, and increased inhibition. (From Smith and Reynard, Textbook of Pharmacology, 1991, p337)

Peripheral Arterial Disease: Lack of perfusion in the EXTREMITIES resulting from atherosclerosis. It is characterized by INTERMITTENT CLAUDICATION, and an ANKLE BRACHIAL INDEX of 0.9 or less.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lüscher, TF1

Other Studies

1 other study available for acetazolamide and Peripheral Arterial Disease

ArticleYear
Pulmonary embolism and pulmonary hypertension: two issues often neglected in cardiology.
    European heart journal, 2015, Mar-07, Volume: 36, Issue:10

    Topics: Acetazolamide; Antihypertensive Agents; Humans; Hypertension, Pulmonary; Imatinib Mesylate; Oxygen;

2015